Works matching AU Yoshida, Kazuhiko

Results: 171
    1
    2
    3

    Fibrolamellar carcinoma of the liver in the orient.

    Published in:
    Journal of Surgical Oncology, 1988, v. 39, n. 3, p. 187, doi. 10.1002/jso.2930390311
    By:
    • Yoshida, Kazuhiko;
    • Amemiya, Atsushi;
    • Kobayashi, Susumu;
    • Sakurai, Kenji;
    • Suzuki, Masaki;
    • Aizawa, Sigeru
    Publication type:
    Article
    4

    Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma.

    Published in:
    Cancer Diagnosis & Prognosis, 2024, v. 4, n. 4, p. 496, doi. 10.21873/cdp.10354
    By:
    • NANAKA KATSURAYAMA;
    • HIROKI ISHIHARA;
    • RYO ISHIYAMA;
    • YUKI NEMOTO;
    • TAKASHI IKEDA;
    • SHINSUKE MIZOGUCHI;
    • TAKAYUKI NAKAYAMA;
    • HIRONORI FUKUDA;
    • KAZUHIKO YOSHIDA;
    • JUNPEI IIZUKA;
    • HIROAKI SHINMURA;
    • YASUNOBU HASHIMOTO;
    • TSUNENORI KONDO;
    • TOSHIO TAKAGI
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1208, doi. 10.1093/jjco/hyac099
    By:
    • Yoshino, Maki;
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Nishimura, Koichi;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Toki, Daisuke;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    11
    12
    13

    Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1751, doi. 10.1093/jjco/hyab142
    By:
    • Ishihara, Hiroki;
    • Kondo, Tsunenori;
    • Nakamura, Kazutaka;
    • Nemoto, Yuki;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Takagi, Toshio
    Publication type:
    Article
    14
    15

    Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 793, doi. 10.1093/jjco/hyaa232
    By:
    • Ishihara, Hiroki;
    • Takagi, Toshio;
    • Kondo, Tsunenori;
    • Fukuda, Hironori;
    • Tachibana, Hidekazu;
    • Yoshida, Kazuhiko;
    • Iizuka, Junpei;
    • Kobayashi, Hirohito;
    • Okumi, Masayoshi;
    • Ishida, Hideki;
    • Tanabe, Kazunari
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.

    Published in:
    Clinical Genitourinary Cancer, 2023, v. 21, n. 1, p. 136, doi. 10.1016/j.clgc.2022.08.001
    By:
    • Hiroki Ishihara;
    • Yudai Ishiyama;
    • Yuki Nemoto;
    • Kazutaka Nakamura;
    • Hidekazu Tachibana;
    • Hironori Fukuda;
    • Kazuhiko Yoshida;
    • Hirohito Kobayashi;
    • Junpei Iizuka;
    • Hiroaki Shimmura;
    • Yasunobu Hashimoto;
    • Kazunari Tanabe;
    • Tsunenori Kondo;
    • Toshio Takagi
    Publication type:
    Article
    25
    26

    Survival Impact of Glucocorticoid Administration for Adverse Events During Immune Checkpoint Inhibitor Combination Therapy in Patients with Previously Untreated Advanced Renal Cell Carcinoma.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 4, p. 623, doi. 10.1007/s11523-024-01069-6
    By:
    • Yoshino, Maki;
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Mizoguchi, Shinsuke;
    • Ikeda, Takashi;
    • Nakayama, Takayuki;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    27

    Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study

    Published in:
    Targeted Oncology, 2023, v. 18, n. 2, p. 209, doi. 10.1007/s11523-023-00956-8
    By:
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Tachibana, Hidekazu;
    • Ikeda, Takashi;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    28
    29

    Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era.

    Published in:
    Targeted Oncology, 2022, v. 17, n. 3, p. 307, doi. 10.1007/s11523-022-00879-w
    By:
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    30

    Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study.

    Published in:
    2021
    By:
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Ikeda, Takashi;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Takagi, Toshio;
    • Ishida, Hideki;
    • Kondo, Tsunenori;
    • Tanabe, Kazunari
    Publication type:
    journal article
    31
    32
    33
    34
    35
    36

    Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03876-2
    By:
    • Ishihara, Hiroki;
    • Fukuda, Hironori;
    • Mizoguchi, Yukihiro;
    • Yamashita, Makiko;
    • Aoki, Kazunori;
    • Ishiyama, Ryo;
    • Ikeda, Takashi;
    • Nemoto, Yuki;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Yoshida, Kazuhiko;
    • Hirai, Toshihito;
    • Iizuka, Junpei;
    • Tokita, Daisuke;
    • Kondo, Tsunenori;
    • Nagashima, Yoji;
    • Takagi, Toshio
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50